68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter

Nuclear Medicine and Biology

Volumn 39, Issue 7, 2012, Pages 993-999

  Fellner, M ^a   Biesalski, B ^c   Bausbacher, N ^c   Kubicek V ^b   Hermann, P ^b   Rosch F ^a   Thews, O ^d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Bisphosphonate; Bone metastases; Ga 68; Macrocylic ligand

Indexed keywords

[4 [[BIS(PHOSPHONOMETHYL)CARBAMOYL]METHYL] 7,10 BIS(CARBOXYMETHY) 1,4,7,10 TETRAAZACYCLODODEC 1 YL]ACETIC ACID GA 68; GALLIUM 68; GERMANIUM 68; HYDROXYAPATITE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING KINETICS; BONE METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYCLOTRON; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG STABILITY; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; TEMPERATURE;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; DIPHOSPHONATES; DURAPATITE; ELECTRONS; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RATS;

EID: 84866042438     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.04.007     Document Type: Article

References (23)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001, 51:15-36.
2. Rubens R.D. Bone metastases-the clinical problem. Eur J Cancer 1998, 34:210-213.
3. Zettinig G., Leitha T., Niederle B., Kaserer K., Becherer A., Kletter K., et al. FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma. Clin Nucl Med 2001, 26:599-601.
4. Harmer C.L., Burns J.E., Sams A., Spittle M. The value of fluorine-18 for scanning bone tumours. Clin Radiol 1969, 20:204-212.
5. 99Mo shortage in nuclear medicine: crisis or challenge?. J Label Compd Radiopharm 2012, 53:167-168.
6. Gould P. Medical isotope shortage reaches crisis level. Nature 2009, 460:312-313.
7. 68Ga-DOTATOC. Nucl Med Biol 2008, 35:721-724.
8. 68Ga for medical application. J Nucl Med 2007, 48:1741-1748.
9. 68Ga for PET-imaging of bone metabolism. Radiochim Acta 2011, 99:43-51.
10. Papapoulos S.E. Bisphosphonates: how do they work?. Best Pract Res Clin Endocrinol Metab 2008, 22:831-847.
11. Kubícek V., Rudovský J., Kotek J., Hermann P., Vander Elst L., Muller R.N., et al. A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting. J Am Chem Soc 2005, 127:16477-16485.
12. Vitha T., Kubícek V., Hermann P., Vander Elst L., Muller R.N., Kolar Z.I., et al. Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy. J Med Chem 2008, 51:677-683.
13. 68Ga-bisphosphonates: first human study. Eur J Nucl Med Mol Imaging 2010, 37:834.
14. Ebetino F.H., Rozé Z.N., McKenna C.E., Barnett B.L., Dunford J.E., Russell R.G.G., et al. Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase. J Organomet Chem 2005, 690:2679-2687.
15. Workman P., Twentyman P., Balkwill F., Balmain A., Chaplin D.J., Double J.A., et al. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (2nd edit.). Br J Cancer 1998, 77:1-10.
16. Kostenuik P.J., Singh G., Suyama K.L., Orr F.W. A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells. Clin Exp Metastasis 1992, 10:403-410.
17. Biesalski B., Yilmaz B., Buchholz H.G., Bausbacher N., Schreckenberger M., Thews O. An allogenic site-specific rat model of bone metastases for nuclear medicine and experimental oncology. Nucl Med Biol 2011, 39:502-506.
18. OEt). J Inorgan Biochem 2008, 102:1531-1540.
19. 68Ga]-EDTMP. Nucl Med Biol 2007, 34:391-397.
20. Okamoto Y. Accumulation of technetium-99m methylene diphosphonate. Conditions affecting adsorption to hydroxyapatite. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 80:115-119.
21. Brunetti A., Blasberg R.G., Finn R.D., Larson S.M. Gallium-transferrin as a macromolecular tracer of vascular permeability. Int J Rad Appl Instrum B 1988, 15:665-672.
22. Ferreira C.L., Lamsa E., Woods M., Duan Y., Fernando P., Bensimon C., et al. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals. Bioconjug Chem 2010, 21:531-536.
23. Bäuerle T., Adwan H., Kiessling F., Hilbig H., Armbruster F.P., Berger M.R. Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int J Cancer 2005, 115:177-186.